Cancer-Preventive Rexinoid Modulates Neutral Lipid Contents of Mammary Epithelial Cells through a Peroxisome Proliferator-Activated Receptor γ-Dependent Mechanism

Synthetic rexinoids effectively suppress both estrogen receptor-positive and estrogen receptor-negative mammary tumors in animal models, which makes them prime candidates for a novel class of cancer-preventive agents. When used in combination with chemotherapy for non–small-cell lung cancer, the rex...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Uray, Iván P., Rodenberg, Jennifer M., Bissonnette, Reid P., Brown, Powel H., Mancini, Michael A.
Formato: Artigo
Lenguaje:Inglês
Publicado: The American Society for Pharmacology and Experimental Therapeutics 2012
Materias:
Articles
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3263950/
https://ncbi.nlm.nih.gov/pubmed/22053058
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/mol.111.072967
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares